1/20
Looks like no tags are added yet.
Peroxisome function
Detoxification of reactive oxygen species; fatty acid oxidation
Peroxisomal disorders categories
Group I: biogenesis defects; Group II: enzyme defects; Group III: normal peroxisomes but multiple defective enzymes
Zellweger syndrome inheritance
Autosomal recessive
Zellweger syndrome alternate name
Cerebro‑hepato‑renal syndrome
Zellweger syndrome hallmark
Typical dysmorphic facies
Zellweger syndrome organ involvement
Progressive degeneration of brain, liver, kidney
Zellweger syndrome prognosis
Death ~6 months after onset of liver/kidney failure
Zellweger syndrome biochemical test
Serum very long chain fatty acids (VLCFAs)
Zellweger syndrome diagnostic biopsy
Staining for peroxisomes
Peroxisomal β‑oxidation
Oxidation of very long chain fatty acids
VLCFA accumulation
Indicates peroxisomal dysfunction
Peroxisomal biogenesis genes
PEX genes
PEX gene mutations
Cause failure to form functional peroxisomes
Peroxisomal enzyme defects
Cause accumulation of specific substrates
Group III peroxisomal disorders
Normal peroxisomes but multiple enzyme defects
Peroxisomal ROS detoxification
Breakdown of hydrogen peroxide via catalase
Peroxisomal plasmalogen synthesis
Important for myelin and neuronal membranes
Peroxisomal disorder symptoms
Neurological dysfunction, liver disease, hypotonia
Peroxisomal disorder onset
Often neonatal or early infancy
Peroxisomal disorder diagnosis
Biochemical testing + genetic sequencing